Literature DB >> 11843169

Levels of circulating intercellular adhesion molecule-1 in patients with Behçet's disease.

Kenan Saglam1, M Ilker Yilmaz, Ayse Saglam, Mete Ulgey, Fatih Bulucu, Yavuz Baykal.   

Abstract

The purpose of this study was to investigate the possible relationship between circulating intercellular adhesion molecule-1 (cICAM-1) plasma levels and Behçet's disease. Plasma levels of cICAM-1 were measured in 44 patients with Behçet's disease and in 30 healthy controls. cICAM-1 levels were higher in patients with Behçet's disease than in the controls (P=0.001). The difference was more marked between patients with active Behçet's disease and controls (P < 0.001). cICAM-1 levels were also higher in patients with active Behçet's disease than in those with inactive disease (P<0.001). cICAM-1 seems to be related to disease activity in Behçet's disease. It may be useful in assessing disease activity in Behçet's disease, as well as in monitoring response to treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11843169     DOI: 10.1007/s00296-001-0148-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  6 in total

1.  Interferon-beta and adhesion molecules (E-selectin and s-intracellular adhesion molecule-1) are detected in sera from patients with retinal vasculitis and are induced in retinal vascular endothelial cells by Toll-like receptor 3 signalling.

Authors:  M T Lee; L C Hooper; L Kump; K Hayashi; R Nussenblatt; J J Hooks; B Detrick
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

2.  Peripheral arterial disease in patients with Behçet's disease.

Authors:  Ilknur Balta; Sevket Balta; Sait Demirkol; Ozlem Ekiz
Journal:  Rheumatol Int       Date:  2013-03-28       Impact factor: 2.631

3.  Morphologic evidence of subclinical atherosclerosis obtained by carotid ultrasonography in patients with Behcet's disease.

Authors:  Mehmet Akif Oztürk; Suna O Oktar; Selman Unverdi; Kemal Ureten; Berna Göker; Seminur Haznedaroglu; Gülten Sungur; Kadriye A Reis; A Mesut Onat
Journal:  Rheumatol Int       Date:  2006-01-10       Impact factor: 2.631

4.  Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease.

Authors:  Fuat Erdem; Mehmet Gündoğdu; Ilhami Kiki; Refik Ali Sari; Ahmet Kiziltunç
Journal:  Rheumatol Int       Date:  2004-07-15       Impact factor: 2.631

5.  Vascular endothelial growth factor and carotid intima-media thickness in patients with Behçet's disease.

Authors:  Mehmet Akif Oztürk; Selman Unverdi; Suna O Oktar; Neslihan Bukan; Ozlem Gülbahar; Kemal Ureten; Berna Göker; Seminur Haznedaroglu; Gülten Sungur; Tansu Ulukavak Ciftçi; A Mesut Onat
Journal:  Clin Rheumatol       Date:  2008-01-18       Impact factor: 2.980

6.  Gene Expression Profiling in Behcet's Disease Indicates an Autoimmune Component in the Pathogenesis of the Disease and Opens New Avenues for Targeted Therapy.

Authors:  Antonio Puccetti; Piera Filomena Fiore; Andrea Pelosi; Elisa Tinazzi; Giuseppe Patuzzo; Giuseppe Argentino; Francesca Moretta; Claudio Lunardi; Marzia Dolcino
Journal:  J Immunol Res       Date:  2018-04-24       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.